BE858147A - Nouvelles heterocyclo-omega-pentanorprostaglandines aryliques substituees en position 2 et medicament les contenant - Google Patents

Nouvelles heterocyclo-omega-pentanorprostaglandines aryliques substituees en position 2 et medicament les contenant

Info

Publication number
BE858147A
BE858147A BE180460A BE180460A BE858147A BE 858147 A BE858147 A BE 858147A BE 180460 A BE180460 A BE 180460A BE 180460 A BE180460 A BE 180460A BE 858147 A BE858147 A BE 858147A
Authority
BE
Belgium
Prior art keywords
pentanorprostaglandins
arylic
heterocyclo
omega
substitutes
Prior art date
Application number
BE180460A
Other languages
English (en)
French (fr)
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of BE858147A publication Critical patent/BE858147A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/80Radicals substituted by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/54Quaternary phosphonium compounds
    • C07F9/5407Acyclic saturated phosphonium compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6524Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having four or more nitrogen atoms as the only ring hetero atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/655Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
    • C07F9/65515Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a five-membered ring
    • C07F9/65517Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a five-membered ring condensed with carbocyclic rings or carbocyclic ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Furan Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
BE180460A 1976-08-27 1977-08-26 Nouvelles heterocyclo-omega-pentanorprostaglandines aryliques substituees en position 2 et medicament les contenant BE858147A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US71810776A 1976-08-27 1976-08-27

Publications (1)

Publication Number Publication Date
BE858147A true BE858147A (fr) 1978-02-27

Family

ID=24884845

Family Applications (1)

Application Number Title Priority Date Filing Date
BE180460A BE858147A (fr) 1976-08-27 1977-08-26 Nouvelles heterocyclo-omega-pentanorprostaglandines aryliques substituees en position 2 et medicament les contenant

Country Status (9)

Country Link
JP (1) JPS5328159A (xx)
BE (1) BE858147A (xx)
DE (1) DE2737808A1 (xx)
DK (1) DK379477A (xx)
FR (1) FR2362849A1 (xx)
GB (1) GB1542569A (xx)
IE (1) IE46257B1 (xx)
LU (1) LU78037A1 (xx)
NL (1) NL7709444A (xx)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1012137B1 (en) * 1997-09-09 2002-11-06 The Procter & Gamble Company Aromatic c16-c20-substituted tetrahydro prostaglandins useful as fp agonists
US5977173A (en) * 1997-09-09 1999-11-02 Wos; John August Aromatic C16 -C20 -substituted tetrahydro prostaglandins useful as FP agonists
DE69832513T2 (de) * 1997-09-09 2006-07-13 Duke University Aromatische c16-c20-substituierte tetrahydro-prostaglandinen verwendbar wie fp agoniste
NZ513825A (en) * 1999-03-05 2001-09-28 Procter & Gamble C 16 unsaturated FP-selective prostaglandins analogs
US20020013294A1 (en) 2000-03-31 2002-01-31 Delong Mitchell Anthony Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
US20020172693A1 (en) 2000-03-31 2002-11-21 Delong Michell Anthony Compositions and methods for treating hair loss using non-naturally occurring prostaglandins
US20020037914A1 (en) 2000-03-31 2002-03-28 Delong Mitchell Anthony Compositions and methods for treating hair loss using C16-C20 aromatic tetrahydro prostaglandins
US8623918B2 (en) 2008-10-29 2014-01-07 Novaer Holdings, Inc. Amino acid salts of prostaglandins
US8722739B2 (en) 2008-10-29 2014-05-13 Novaer Holdings, Inc. Amino acid salts of prostaglandins
JP6111672B2 (ja) * 2013-01-10 2017-04-12 株式会社ニコン フォトマスク用基板およびフォトマスク

Also Published As

Publication number Publication date
LU78037A1 (fr) 1979-05-23
NL7709444A (nl) 1978-03-01
GB1542569A (en) 1979-03-21
JPS5539554B2 (xx) 1980-10-13
FR2362849B1 (xx) 1980-07-11
FR2362849A1 (fr) 1978-03-24
IE46257B1 (en) 1983-04-20
DE2737808A1 (de) 1978-03-16
DK379477A (da) 1978-02-28
IE46257L (en) 1978-02-27
JPS5328159A (en) 1978-03-16

Similar Documents

Publication Publication Date Title
BE871907A (fr) Nouveaux 1,9-dihydroxyoctahydrophenanthrenes et medicament les contenant
BE846335R (fr) (polyalcoxy-phenyl)-4-pyrrolidinones-2 et medicaments qui en contiennent
BE860877A (fr) Spirolactones steroidiques et medicaments qui en contiennent
FR2295739A1 (fr) Oxo-20 homopregnanes et medicaments qui en contiennent
BE849788A (fr) Ethers d'imidazolyl-oximes et medicaments qui en contiennent
FR2326927A1 (fr) Steroides insatures en 15 et medicaments qui en contiennent
FR2281123A1 (fr) Oxo-20 pregnanes et medicaments qui en contiennent
BE850883A (fr) Nonapeptides et compositions therapeutiques en contenant
BE858608A (fr) Melanges contenant des polydiorganosiloxanes et leur preparation
BE858147A (fr) Nouvelles heterocyclo-omega-pentanorprostaglandines aryliques substituees en position 2 et medicament les contenant
BE869166A (fr) Nouvelles 4-pyrones substituees en positions 2, 3 et 6 et medicament les contenant
FR2338936A1 (fr) Nouvelles 1,2-benzisothiazolinones-3, leur procede de preparation et medicament les contenant
FR2342990A1 (fr) Androstenones et medicaments qui en contiennent
BE863619A (fr) 4"-deoxy-4"- (amino substitue)-oleandomycines et medicament les contenant
BE862433A (fr) Compositions medicamenteuses contenant des sterolines et leurs applications therapeutiques
FR2349585A1 (fr) Nouveau derive de xanthine et composition pharmaceutique le contenant
FR2342973A1 (fr) Azapurines et medicaments contenant ces substances
FR2352790A1 (fr) Nouveaux benzamides n-(acyl)-p-amino-n'-monosubstitues et composition pharmaceutique les contenant
JPS52133982A (en) Novel imidazolyll*4**oxyypropanolamine derivartive* prparation thereof and medicine containing same and having barrier effect against betaaacceptor
JPS5362834A (en) Pharmaceutical composition and use thereof
FR2342971A1 (fr) Derives de la purine et medicament contenant ces substances
FR2343477A1 (fr) Nouvelles phenylpyridylhydantoines substituees et medicament les contenant
BE857535A (fr) Nouvelles organoprostaglandines et medicament les contenant
FR2343482A1 (fr) La 2- (2-acetamido-2-deoxy-3-o-d-glucopyranosyl) -d-propionyl-l-seryl-d-isoglutamine et medicaments la contenant
BE847820A (fr) Nouveaux derives d'hydroxyanilino-hexahydro-2h-benzo (q)-quinolizines substituees en position 2 et medicament les contenant,

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: PFIZER INC.

Effective date: 19860831